Cent Eur J Public Health 2016, 24(1):29-38
Human Papillomavirus Vaccine - Knowledge and Attitudes among Parents of Children Aged 10-14 Years: a Cross-sectional Study, Tîrgu Mureş, Romania
- 1 Department of Epidemiology, University of Medicine and Pharmacy of Tîrgu Mureş, Romania
- 2 Department of Community Nutrition, University of Medicine and Pharmacy of Tîrgu Mureş, Romania
- 3 Department of Dermatology, University of Medicine and Pharmacy of Tîrgu Mureş, Romania
- 4 University of Medicine and Pharmacy of Tîrgu Mureş, Romania
- 5 Department of Laboratory Medicine, University of Medicine and Pharmacy of Tîrgu Mureş, Romania
Aim: Romania ranks first in Europe in terms of mortality from cervical cancer, recording 6.3 times more deaths than the mean in EU countries. Although vaccination campaigns were launched by health officials in Romania, the acceptance rate remained insignificant and programmes were discontinued. A successful vaccination programme requires a high rate of acceptance and accurate information for health professionals and parents. The aim of the study was to evaluate the level of parental knowledge about human papilomavirus (HPV) infection and HPV vaccination including the information obtained from general practitioners and identification of barriers in implementing a vaccination strategy.
Methods: We performed a cross-sectional study using a self-administered questionnaire for the parents of pupils in grades 5-8, in three randomly selected secondary schools in Tîrgu Mureş, Romania.
Results: We surveyed 918 parents. Of the respondents, 85.8% have heard of HPV infection. Most reported an average level of knowledge about HPV infection and HPV vaccination. The two main sources of information were specialized healthcare professionals (42.8% for HPV infection, 39.1% for HPV vaccination) and the Internet browsing (42.3% and 42.9%, respectively). Based on current knowledge, only one third of parents would have their child vaccinated against HPV infection. According to most parents surveyed, the main reasons for not wanting to have their child vaccinated is the fear of side effects; the vaccine is new and insufficiently studied; or parents do not know details about the vaccine.
Conclusions: The parents showed the average level of knowledge about HPV infection and HPV vaccination. The implementation of an effective programme to increase the acceptance rate of HPV vaccination requires educational strategies aimed at involving parents and their children and supported by general practitioners and public health professionals.
Klíčová slova: HPV infection, cervical cancer, HPV vaccination, questionnaire, parents
Vloženo: 30. leden 2015; Revidováno: 11. červen 2015; Přijato: 11. červen 2015; Zveřejněno: 1. březen 2016 Zobrazit citaci
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Reference
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12-9.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Bosch FX, LorinczA, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr;55(4):244-65.
Přejít k původnímu zdroji...
- Palefsky JM, GiulianoAR, Goldstone S, Moreira ED Jr,Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011 Oct 27;365(17):1576-85.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518-27.
Přejít k původnímu zdroji...
Přejít na PubMed...
- International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon: IARC; 2016 [cited 2016 Mar 8]. Available from: http://globocan.iarc.fr.
- Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705-8.
- Hendry M, Lewis R, ClementsA, Damery S, Wilkinson C. "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013 Oct 25;31(45):5152-67.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009 Jul 25;374(9686):301-14.
Přejít k původnímu zdroji...
Přejít na PubMed...
- McCormack PL, Joura EA. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women. Drugs. 2010 Dec 24;70(18):2449-74.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Cervarix (human papillomavirus bivalent vaccine, recombinant intramuscular injection) product information. Research Triangle Park (NC): GlaxoSmithKline; 2009.
- Penţa MA, Băban A. Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania. Int J Behav Med. 2014 Feb;21(1):20-8.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Craciun C, BabanA. "Who will take the blame?": understanding the reasons why Romanian mothers decline HPV vaccination for their daughters. Vaccine. 2012 Nov 6;30(48):6789-93.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine. 2013 Mar 25;31(13):1673-9.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Fagot JP, Boutrelle A, Ricordeau P, Weill A, Allemand H. HPV vaccination in France: uptake, costs and issues for the National Health Insurance. Vaccine. 2011 Apr 27;29(19):3610-6.
Přejít k původnímu zdroji...
Přejít na PubMed...
- LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011 Nov 1;89(11):821-830B.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012 May 21;30(24):3546-56.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):363-72.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Cates JR, ShaferA, Carpentier FD, Reiter PL, Brewer NT, McReeAL, et al. How parents hear about human papillomavirus vaccine: implications for uptake. J Adolesc Health. 2010 Sep;47(3):305-8.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Penţa MA, Băban A. Mass media coverage of HPV vaccination in Romania: a content analysis. Health Educ Res. 2014 Dec;29(6):977-92.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Giambi C, D'Ancona F, Del Manso M, De Mei B, Giovannelli I, Cattaneo C, et al.; Local Representatives for VALORE. Exploring reasons for non-vaccination against human papillomavirus in Italy. BMC Infect Dis. 2014 Nov 11;14:545. doi: 10.1186/s12879-014-0545-9.
Přejít k původnímu zdroji...
Přejít na PubMed...
- FirenzeA, Marsala MG, Bonanno V, Maranto M, Ferrara C, Giovannelli L, et al. Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation. Hum Vaccin Immunother. 2015;11(1):240-4.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Hanley SJ, Yoshioka E, Ito Y, Konno R, Hayashi Y, Kishi R, et al. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls.Vaccine. 2012Aug 24;30(39):5740-7.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, JacquardAC, Régnier V, et al. French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 - 18 year old daughters: a quantitative-qualitative study. BMC Public Health. 2012 Nov 27;12:1034. doi: 10.1186/14712458-12-1034.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005 Dec;18(6):391-8.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005 Dec;37(6):502-10.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Patel PR, Berenson AB. Sources of HPV vaccine hesitancy in parents. Hum Vaccin Immunother. 2013 Dec;9(12):2649-53.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. JAdolesc Health. 2008 Sep;43(3):239-45.
Přejít k původnímu zdroji...
Přejít na PubMed...
- European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries: Stockholm, January 2008. Stockholm: ECDC; 2008.
- Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec. 2009 Apr 10;84(15):118-31.
Přejít na PubMed...